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Background: The ansamycin class of antibiotics are produced by various 
Actinomycetes. Their carbon framework arises from the polyketide pathway 
via a polyketide synthase (PKS) that uses an unusual starter unit. Rifamycin 
(rif), produced by Amycolatopsis mediterranei, is the archetype ansamycin 
and it is medically important. Although its basic precursors (3-amino-5- 
hydroxy benzoic acid AHBA, and acetic and propionic acids) had been 
established, and several biosynthetic intermediates had been identified, very 
little was known about the origin of AHBA nor had the PKS and the various 
genes and enzymes that modify the initial intermediate been characterized. 
Results: A set of 34 genes clustered around the rifKgene encoding AHBA 
synthase were defined by sequencing all but 5 kilobases (kb) of a 95 kb 
contiguous region of DNA from A. mediterraneL The involvement of some of 
the genes in the biosynthesis of rifamycin B was examined. At least five genes 
were shown to be essential for the synthesis of AHBA, five genes were 
determined to encode the modular type I PKS that uses AHBA as the starter 
unit, and 20 or more genes appear to govern modification of the polyketide- 
derived framework, and rifamycin resistance and export. Putative regulatory 
genes were also identified. Disruption of the PKS genes at the end of rifA 
abolished rifamycin B production and resulted in the formation of P8/1-OG, a 
known shunt product of rifamycin biosynthesis, whereas disruption of the orf6 
and orf9 genes, which may encode deoxysugar biosynthesis enzymes, had no 
apparent effect. 
Conclusions: Rifamycin production in A. mediterranei is governed by a 
single gene cluster consisting of structural, resistance and export, and 
regulatory genes. The genes characterized here could be modified to produce 
novel forms of the rifamycins that may be effective against rifamycin-resistant 
microorganisms. 
Addresses: 1Department ofChemistry, Box 351700, 
University of Washington, Seattle, WA 98195-1700, 
USA. 2School of Pharmacy, University of Wisconsin, 
425 North Charter Street, Madison, WI53706, USA. 
Present addresses: tMDS-Panlabs, Inc., 11804 
North Creek Parkway, S. Bothell, WA 98011-8805, 
USA. *lnstitut fuer Pharmazeutische Biologie der 
Universitaet, NuBallee 6, D-53115 Bonn 1, Germany. 
§Department of Chemical Engineering B-419, Inje 
University, Obang-dong 607, Kimhae, Kyongnam 
621-749, Korea. 
*Contributed equally to this work. 
Correspondence: C Richard Hutchinson 
and Heinz G Floss 
e-mail: crhutchi@facstaff.wisc.edu and 
floss@chem.washington.edu 
Key words: 3-amino-5-hydroxy benzoic acid, 
combinatorial biosynthesis, gene disruption, modular 
type I polyketide synthase, shikimate pathway 
Received: 29 December 1997 
Revisions requested: 14 January 1998 
Revisions received: 19 January 1998 
Accepted: 20 January 1998 
Published: 13 February 1998 
Chemistry & Biology February 1998, 5:69-79 
http://biomednet.com/elecref/10?4552100500069 
© Current Biology Ltd ISSN 1074-5521 
Introduction 
The ansamycins are a prominent class of antibiotics pro- 
duced by various Actinomycetes. Structurally they are 
characterized by a macrocycle composed of a benzenic or 
naphthalenic chromophore bridged by an aliphatic ansa 
chain that terminates at the chromophore in an amide 
linkage. Structural features that distinguish the various 
ansamycin antibiotics include the macrocycle chain 
length, chromophore type and degree of post-synthetic 
modification. Examples of ansamycins include the 
ansamitocins, geldanamycins, treptovaricins and naph- 
thomycins [1]. Rifamycin B (Figure 1) [2,3], produced by 
Amycolatopsis mediterranei, is one of the most notable 
members of the ansamycin family. It has been used clini- 
cally in a synthetically modified form called rifampicin 
since the mid 1960s, and it is still one of the first-line ther- 
apies effective in the treatment of tuberculosis and other 
mycobacterial infections [4]. 
Feeding experiments using labeled precursors have shown 
that the ansa chain of rifamycin is biosynthesized from pro- 
pionate and acetate units [5,6] in a manner that suggests 
assembly on a muhifunctional type I polyketide synthase 
(PKS) [7]. The starter unit for this polyketide assembly, 
called the mC7N unit, is part of the chromophore and is 
derived from 3-amino-5-hydroxybenzoic ac d(AHBA) [8]. 
AHBA, according to recent cell-free experiments, arises 
from a new metabolic route, the aminoshikimate pathway, 
that parallels the early steps of the shikimate pathway 
(Figure 1) [9]. The aminoshikimate pathway leads to the 
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Comparison of the early shikimate pathway with the alternate 
aminoshikimate pathway as proposed by Kim et a/. [9] and its connection 
with rifamycin B biosynthesis. Color coding indicates the portions of 
rifamycin B resulting from AHBA (green), malonyl-CoA and 
methylmalonyI-CoA (red), molecular oxygen (blue), and other sources 
(black). DAHP, 3-deoxy-D-arabino-heptulosonate 7-phosphate; DHQ, 
dehydroquinate; DHS, dehydroshikimic acid; PEP, phosphoenolpyruvate; 
E4P, erythrose-4-phosphate. 
formation of 5-deoxy-5-amino-3-dehydroshikimic acid 
(aminoDHS) which is then aromatized to AHBA by a 
novel pyridoxal phosphate enzyme, AHBA synthase. 
Cloning of the gene encoding this enzyme, HfK, and 
demonstration that this gene is essential for rifamycin pro- 
duction [10] then provided a probe that allowed the isola- 
tion of the rifamycin biosynthetic gene cluster. The 
sequence and functional analysis of this cluster is the 
subject of the present report. 
Resu l ts  
Kim et aL [101 established that the AHBA synthase gene 
product is essential for the biosynthesis of the mCTN 
unit of rifamycin. Given the precedent for the clustering 
of related biosynthetic genes in Actinomycetes [11], we 
proceeded to isolate and sequence DNA flanking the 
rifK gene in order to identify the rifamycin biosynthetic 
gene cluster (Figure 2). Approximately 90 kilobases (kb) 
of DNA were sequenced: one region was obtained from 
the primary cosmid clones pFKN108 and pFKN105; 
when pFKN108 containing part of the PKS genes was 
found to be prone to deletions and rearrangements, he 
PKS genes were then obtained as several overlapping 
clones from DNA mini-libraries made in plasmid vectors. 
Computer-assisted analysis of the nucleotide sequence 
revealed open reading frames (ORFs) homologous to 
genes involved in the shikimate pathway of plants and 
bacteria, various putative modifying and regulatory 
genes as well as five large ORFs coding for a modular 
type I PKS (Figure 2). Genes sequenced and the actual 
or putative functions of some of their gene products are 
listed in Table 1. 
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Figure 2 
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Genetic organization of the rifamycin biosynthetic gene cluster. For 
comparison, the acyl chain of the rifamycin polyketide is placed over 
the respective modules (the loading domain L and modules 1-10) 
believed to be involved in the incorporation of the appropriate 
extender units, indicated by thick red (for propionate-derived) or pink 
(for acetate-derived) arrows, with the AHBA starter unit shown i
green. Groupings of the restriction map are based upon biosynthetic 
functions (see text). Genes are colored according to proven or likely 
functions: AHBA biosynthesis (green), PKS (red), oxygenation by 
CYP450 enzymes (blue) and regulation or resistance (yellow). 
Nudeotide sequence of the rifamycin mCTN unit 
biosynthetic genes 
Proximate to the previously characterized rifK gene [10], 
there are a number of genes that form a sub-cluster and 
potentially an operon that appears to be responsible for 
the biosynthesis of the mC7N polyketide starter unit 
(Figure 2). A strong transcription terminator sequence 
immediately follows r/fO, which therefore seems to be 
the last gene in a transcription unit starting at least with 
rifK and possibly earlier. The products of several genes 
in this sub-cluster are highly homologous to proteins 
involved in the shikimate biosynthetic and the quinate 
utilization pathways of bacteria, plants and fungi. RifG 
shows a high degree of similarity to Escherichia coli and 
eukaryotic dehydroquinate synthases. 3-Dehydroquinate 
synthase catalyzes the cyclization of 3-deoxy-D-arabino- 
heptulosonate 7-phosphate (DAHP) into 3-dehydro- 
quinate, the second step in the shikimate pathway [12]. 
RifG has the highest degree of similarity to a hypotheti- 
cal ORF from Actinoplanes teichomyceticus followed by sig- 
nificant identity with AroB of E. coil, Salmonella enterica 
serovar ~.phimurium, and AroM, the pentafunctional 
polypeptide of Emericella nidulans [ 13-15]. 
The gene product of rifH shows a high degree of similar- 
ity to the DAHP synthases (DAHPS) of plants and a 
DAHPS involved in phenazine biosynthesis. A similarity 
of 61.8%, 60.0% and 59.6% and identity of 33.8%, 37.4% 
and 37.6% was observed with PhzC of Pseudomonasfluo- 
rescens, AroG of Lycopersicon esculentum and AroG of Ara- 
bidopsis thaliana, respectively. The proteins encoded by 
r/fG and rifH are proposed to be involved in the forma- 
tion of aminoDAHP and its further cyclization to amino- 
DHQ (Figure 1). The rifl gene appears to encode a 
shikimate or quinate dehydrogenase. It shows 63.5% 
similarity and 41.6% identity with the aroE gene product 
of Pseudomonas eruginosa which catalyzes the reversible 
reduction of 3-dehydroshikimate to shikimate. The pres- 
ence of the rifI gene is surprising, as this step or the 
analogous interconversion of aminoDHS and amino- 
shikimate should not be required for AHBA formation. 
The product of r/fK is the previously described AHBA 
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Table 1 
Deduced functions of ORFs in the rifamycin biosynthetic gene duster. 
Polypeptide (gene) Amino acids Sequence similarity Proposed function 
OrfO(offO) 
RifA (rifA) 
Loading domain 
Module 1 
Module 2 
Module 3 
RifB (rifB) 
Module 4 
Module 5 
Module 6 
RifC (rifC) 
Module 7 
RifD (rifD) 
Module 8 
RifE (rifE) 
Module 9 
Module 10 
RifF (tifF) 
Off1 (orfl) 
RifG (rifG) 
RifH (rifH) 
Rift (rifl) 
RifK (rifK) 
RifL (rilL) 
RifM (filM) 
RifN (rifN) 
RifO (fifO) 
Off2 (off2) 
RifP (rifP) 
RifQ (rifQ) 
Orf3 (off3) 
Orf4 (orf4) 
Orf5 (off5) 
Orf6 (off6) 
Orf7 (off;') 
Orf8 (orf8) 
Orf9 (orfg) 
Orfl 0 (orflO) 
Off11 (orfl 1) 
Orfl 2 (off12) 
Orfl 3 (off13) 
Orfl 4 (olf14) 
Orfl 5 (orf15) 
Orfl 6 (orf16) 
Rif/(rifJ) 
397 
4,735 
ChoP Streptomyces p. [55] 
EryA S. erythraea [22] 
5,050 EryA S. erythraea 
1,763 EryA S. erythraea 
1728 EryA S. erythraea 
3,413 EryA S. erythraea " 
260 E.C. 2.3.1.5 G. gallus [30] 
62 
336 AroB E. coil K12 [14] 
441 AroG S. lycopersicum [56] 
263 AroE Synechocystis so. [41] 
388 AHBAS S. collinus (Genbank Z54208 ) [10] 
360 Purl 0 S. ablboniger [16] 
232 CbbzP A. eutrophus [18] 
303 XylR Synechocystis sp. [41] 
261 LmbE M. leprae (Genbank 699274) 
310 Orf8 A. eutrophus [5?] 
525 Ptr S. pristinaespiralis [31] 
242 actlI-Orfl Streptomyces coelicolor [32] 
166 
403 SoyC S. griseus [58] 
421 OrfA S. thermotolerans [59] 
435 RfbH Salmonella enterica [60] 
381 Orf5 S. violaceoruber [61] 
206 StrM S. griseus [62] 
432 YokM B. subtilis (Genbank AF006665) 
330 RdmF S. purpurascens [63] 
- Mer M. thermoautotrophicum [64] 
252 Orf5 S. fradiae [43] 
500 EryF S. erythraea [65] 
272 Erg6 Synechocystis sp. [41] 
590 Orf2 Ft. fascians [66] 
351 SubC S. griseolus [67] 
163 AroD A. pleuropneumoniae [68] 
Cytochrome P450 monooxygenase 
PKS domains: 
CoA ligase ACP 
KS AT DH* KR ACP 
KS AT m ACP 
KS AT KR* ACP 
PKS domains: 
KS AT DH KR ACP 
KS AT DH* KR ACP 
KS AT DH KR ACP 
PKS domains: 
KS AT DH KR ACP 
PKS domains: 
KS AT DH KR ACP 
PKS domains: 
KS AT m DH KR ACP 
KS AT DH KR ACP 
Amide synthase (N-acetyl transferase) 
Unknown 
Aminodehydroquinate synthase 
AminoDAH P synthase 
Aminoquinate dehydrogenase 
AHBA synthase 
Oxidoreductase 
Phosphatase 
Kinase 
Putatively regulation 
Esterase 
(antibiotic efflux/resistance) 
Transcriptional repressor 
Unknown 
Cytochrome 1°450 monooxygenase 
Cytochrome P450 monooxygenase 
dNTP-hexose dehydratase 
dNTP-hexose glycosyl transferase 
dNTP-hexose 3,5 epimerase 
Aminotransferase 
Oxidoreductase 
Reductase 
Thioesterase 
Cytochrome P450 monooxygenase 
Methyltransferase 
Transketolase 
Cytochrome P450 monooxygenase 
Aminodehydroquinate d hydratase 
Potential PKS enzymatic activities are abbreviated as follows: ACP, 
acyl carrier protein; KS, I~-ketoacyI-ACP synthase; AT r", acyltransferase 
utilizing malonyl-CoA as an extender unit (the other ATs use 
methylmalonyI-CoA); KR, I~-ketoacyI-ACP reductase; DH, ~-hydroxy- 
acyl-thioester dehydratase. Enzymatic activities listed for the rif PKS 
proteins are colinear with the sequence of each ORF as listed from left 
to right and top to bottom. Asterisked and italicized omains indicate 
that the assigned enzymatic activity is possibly non-functional or that 
an apparent functional domain does not correspond to the predicted 
final polyketide product respectively (see text). 
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synthase involved in the conversion of aminoDHS into 
AHBA [10]. 
The enzyme ncoded by r/fL shows a high degree of simi- 
larity at the amino terminus to the product ofpurlO which 
is involved in the biosynthesis of the aminoglycoside 
antibiotic puromycin [16]. The gene product of pur10, 
which has been implicated in the oxidation of a hydroxyl to 
a carbonyl group, in turn is similar to the glucose-fructose 
oxidoreductase of Zymomonas mobilis. This enzyme oxi- 
dizes glucose to gluconolactone and reduces fructose to 
sorbitol [17]. RilL also shows a high degree of amino acid 
identity to Orfl0 of the rifamycin biosynthetic gene 
cluster, which is adjacent to a gene that codes for a putative 
pyridoxal phosphate (PLP)-dependent transaminase. Sig- 
nificantly, r/fL homologs are located immediately down- 
stream of all the AHBA synthase genes so far isolated: two 
AHBA synthase genes from Streptomyces ollinus, presum- 
ably involved in naphthomycin and ansatrienin biosynthe- 
sis, one from Actinosynnema pretiosum (E. Leismer, 
unpublished observations) and one from the mitomycin 
biosynthetic gene cluster of Streptomyces lavendulae (D.H. 
Sherman, unpublished observations). The juxtaposition of 
these oxidoreductase g nes with genes coding for PLP- 
dependent proteins may be an indication of coordinated 
catalytic activity of the products of these adjacent genes. 
The product of rifM is similar to a class of phosphatases in 
the CBBY family that appear to be involved in glycolate 
oxidation, specifically converting 2-phosphoglycolate to 
glycolate in the Calvin carbon reduction cycle [18]. A 
phosphoglycolate phosphatase gene, gph, has been found 
in E. coli; the enzyme that is encoded by gph catalyzes the 
dephosphorylation f 2-phosphoglycolate but its physio- 
logical role is unclear [19]. Downstream of rifM is the gene 
designated rifN which codes for a protein that has 
sequence similarity to a glucose kinase from Streptomyces 
coelicolor A3(2) that is involved in glucose catabolite 
repression [20]. At the amino terminus of RifN is the 
amino acid sequence Asp-Val-Gly-Gly-Thr (DVGGT) 
which is essentially identical to the motif found in the 
S. coelicolor enzyme and is believed to constitute part of 
the ATP-binding site in mammalian, yeast and bacterial 
hexokinases [20]. Rifamycin biosynthesis, however, is not 
subject to catabolite repression by glucose (R.M., M.T. 
and H.G.F., unpublished observations) and the observed 
homology for the gene products of rifM and rifN may not 
be indicative of their functions. Both rifM and rifN, as well 
as rifL, were shown by gene inactivation experiments to 
be required for AHBA formation (R.M. and H.G.F., 
unpublished observations). 
Notably absent from the cluster of genes surrounding rifK 
is a gene that has homology to either type I or type II 
dehydroquinate (DHQ) dehydratases, a candidate to code 
for an aminoDHQ dehydratase. As earlier enzymatic work 
had shown that the primary metabolic DHQ dehydratase 
of A. mediterranei does not accept aminoDHQ as a sub- 
strate [21], a separate nzyme catalyzing this dehydration 
must exist. A candidate gene, rifJ, encoding a protein that 
has homology to type II DHQ dehydratases was finally 
located about 30 kb downstream from rifK. Despite its 
remote location, this gene was shown, by insertional inac- 
tivation, to be involved in AHBA formation (X.Z. and 
H.G.F., unpublished observations). 
Nudeotide sequence of the rifamycin polyketide synthase 
genes 
Upstream of the genes for AHBA synthesis lies a large 
region encoding the five PKS genes (Figure 2), as initially 
deduced from the results of Southern analysis with seg- 
ments of the eryA PKS genes [22]. The five proteins 
encoded by rifA-rifE contain ten separate modules, typical 
of type I PKSs [7], the active sites of which largely resem- 
ble those found in fatty acid synthases. RifA contains at 
the amino terminus the loading domain for AHBA, which 
consists of an acyl-CoA ligase linked to an acyl carrier 
protein (ACP), and modules 1-3; RifB contains modules 
4-6, RifC contains module 7, RifD contains module 8 and 
RifE contains modules 9 and 10. Module 2, which only has 
the minimally essential PKS domains ([3-ketoacyl-ACP 
reductase, acyltransferase and ACP), lacks the large block 
of presumed structural protein that lies between the acyl- 
transferase and the I]-ketoacyl-ACP reductase domains of 
all the other modules. The ~-hydroxyacyl-thioester dehy- 
dratase (DH) domains do not all correspond to the pattern 
expected for the proposed structure of the PKS product 
drawn in Figure 2 above the genetic map: modules 6 and 7 
of RifB and RifC appear to contain functional DH 
domains (Figure 3a), yet neither the hypothetical product 
of the PKS nor rifamycin W and rifamycin B (Figure 1) 
have double bonds at the positions corresponding to the 
segments made by modules 6 and 7 of the PKS; DH activ- 
ity in modules 9 and 10 of RifE is predicted to be required 
for the biosynthesis of these three compounds, but the 
DH domains of these two modules do not display a close 
alignment with the active sites of the functional DH 
motifs of rapamycin [23] and erythromycin [22] 
(Figure 3a). This is also true for the DH domain of module 
8 which is not likely to be functional because it has large 
deletions in regions at the carboxyl and amino termini that 
are highly conserved in the functional DH domains. In 
contrast, he DH domains in modules 1 and 5 appear to be 
inactive and the one in module 4 is active, consistent with 
biosynthetic expectations (Figure 3a). All other structural 
features of the RifA-RifE proteins are consistent with 
existing precedents [22-25], including the clear differenti- 
ation of the acyltransferase domains specific for the 
malonyl-CoA or methylmalonyl-CoA substrates [23,24] 
(Figure 3b), the seemingly inactive ~-ketoacyl-ACP reduc- 
tase domain in module 3, and the presence of single 
module proteins [25,26]. Finally, the juxtaposition of the 
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Figure 3 
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A comparison of active-site sequences from various PKSs. 
(a) Comparison of the active-site sequences of DH domains from the 
eight rifamycin (rif) PKS modules (shown i  Figure 2) with DH domains 
with those from two modules of the erythromycin (ery4) [22] and
rapamycin (rap4) [23,24] PKSs. The consensus sequence for the 
probable active site amino acids is shown beneath the rap4 sequence. 
(b) Comparison of the active-site sequences of the ten acyltransferase 
domains from the rif PKS with representatives from the erythromycin 
(ery3 and ery5) and rapamycin (rap5 and rap14) PKSs. The active-site 
region is underlined. 
orf0 CYP450 and rifA-rifE genes may indicate that the 
Orf0 protein hydroxylates C-1 before or during formation 
of the naphthoquinone nucleus of proansamycin X
(Figure 1). A function for three other orfs sequenced 
upstream of orf0 could not be deduced by sequence com- 
parisons with the available databases. 
Several mutants were constructed by disrupting the PKS 
genes at the end of different modules and each strain failed 
to produce rifamycin B and its known precursors (L.T., 
Y.J.Y. and C.R.H., unpublished observations). The mutant 
truncated at the end of RifA produced the triketide P8/1- 
OG as the major product (Figure 1), first identified as a 
shunt product of a rifamycin on-producing strain [27]. The 
formation of P8/1-OG supports the enzymatic functions 
predicted for RifA and, together with the results of oxygen 
labeling studies conducted by Rickards and coworkers [28], 
suggests that proansamycin X (Figure 1) could be an early 
precursor of rifamycin instead of proansamycin A [29]. 
Mutants with disruptions in other rifamycin PKS genes 
produce tetraketide, pentaketide, hexaketide and octake- 
tide intermediates of the polyketide assembly (L.T. and 
C.R.H., unpublished observations). 
Located between the modular polyketide synthase genes 
and the AHBA cluster is an ORF designated rifF. The 
gene product of tifF shows a high degree of similarity to 
arylamine N-acetyl-transferases [30]. These enzymes have 
been shown to detoxify arylamines by acetylating the 
amino group with acetyl-CoA as acetyl donor. The acety- 
lated product is subsequently degraded via catabolic path- 
ways. On the basis of the analogous chemistry involved, 
RifF is proposed to catalyze the release of the completed 
polyketide from the PKS by intramolecular mide forma- 
tion to generate the macrocyclic lactam structure. 
Resistance and regulatory genes 
Without exception, all antibiotic biosynthetic gene clus- 
ters in Actinomycetes contain genes that confer esistance 
to the product on the producing organism. Some of the 
resistance mechanisms involve modification of the sec- 
ondary metabolite or the target site (this is the case for the 
A. mediterranei $699 ~poB gene product, a RNA poly- 
merase subunit; T.L.land C.R.H., unpublished observa- 
tions), whereas others/operate by removing the secondary 
metabolite from the intracellular target by transporting it 
out of the cell. Thelgene product of rifP appears to be 
involved in rifamycin,' resistance in A. mediterranei in the 
latter fashion. RifP is/66.1% identical and 81.2% similar to 
an integral membran~ protein, Ptr, from Streptomyces pri ti- 
naesprialis that confers resistance to pristinamycins I and 
II and rifampicin in/Streptomyces li'vidans [31]. Ptr employs 
the transmembrane(electrochemical proton gradient in an 
antiporter mode to drive the efflux of intracellular antibi- 
otics. It is reasonable to suggest, on the basis of the high 
degree of amino acid conservation, that RifP operates im- 
ilarly to export rifamycin from A. mediterranei. 
Down regulation of secondary metabolic biosynthetic 
gene expression is essential for well-balanced primary 
metabolism (growth). One gene that may be involved in 
transcriptional regulation of the rifamycin biosynthetic 
gene cluster is rifQ. RifQ shows a high degree of similarity 
to a transcriptional repressor encoded by the actlI-orfl 
gene of S. coelicolor [32]. Experimental evidence indicates 
that actI1-Orfl represses the expression of the actlI-orf2 
actinorhodin efflux protein gene until stationary phase is 
reached [33]. Presumably RifQ operates similarly in 
autoregulating the expression of a rifPQ operon. 
Computer-assisted database comparisons failed to reveal 
any homology to the small ORF designated orfl down- 
stream of rifF. The diminutive length of orfl suggests that 
it could encode a transcriptional regulatory protein, but 
there is no evidence for this in the sequence data. 
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RifO, which has a high degree of similarity to the lmbE 
gene product from Mycobacterium leprae and Streptomyces 
lincolnensis, may also be involved in regulation of 
rifamycin biosynthesis. The product of the lmbE gene in 
S. lincolnensis has been suggested, without experimental 
evidence, to be involved in the biosynthesis of the propyl- 
proline precursor of lincomycin [34]. On the other hand, 
RifO is similar to 2',3'-cyclic nucleotide 2"-phosphodi- 
esterases. B factor (3'-(1-butylphosphoryl)adenosine) has 
previously been shown to stimulate rifamycin B synthesis 
at extremely low concentrations [35,36]. It is therefore 
conceivable that RifO controls the levels of B factor. 
Rifamycin-modifying genes 
The biosynthesis of rifamycins proceeds through two 
clearly distinct stages: assembly of a polyketide from the 
AHBA starter unit and malonyl-CoA or methylmalonyl- 
CoA chain extension units to give proansamycin X, fol- 
lowed by elaboration of proansamycin X into first 
rifamycin W, then rifamycin B and, potentially, other 
rifamycins. The cluster contains a number of genes that 
appear to be involved in this further elaboration of the 
rifamycin structures from proansamycin X. In addition to 
orfO, orfs 4, 5, 13 and 16 also code for proteins highly 
homologous to CYP450 monooxygenases that may be 
involved in some of the oxidative modification steps that 
occur at C-34a and in the carbon chain cleavage between 
C-12 and C-29 or naphthoquinone formation. The orfll 
gene product shows similarity to the coenzyme F420- 
dependent NSNl°-methylenetetrahydro-methanopterin 
reductase (MER) from Methanobacterium thermoautotroph- 
icum, a member of the kingdom Archea [37]. This protein 
is also similar to the products of a Mycobacterium tuberculosis 
gene of unknown function and the lmbY gene of S. lincol- 
nensis involved in lincomycin biosynthesis [34]. Orf2 codes 
for another protein that is highly homologous to a Mycobac- 
terium gene product of unknown function [37]. This 
protein and Orf2 share a high degree of identity with 
esterases, particularly with lipases. 
Curiously, located upstream of orf5 is a set of genes (orfs 6, 
7, 8, 9 and 10) that appear to encode the formation of an 
amino-deoxyhexose nucleotide. It is predicted that Orf6 
catalyzes reductive 3-deoxygenation of a deoxyhexose 
nucleotide, Orf8 catalyzes epimerization from the D to the 
L series, Orf9 catalyzes amination of a keto group to the 
aminosugar and Orf7 catalyzes transfer of the sugar moiety 
to an aglycone. OrflO encodes an oxidoreductase imilar to 
R i l l  and like rifL is associated with a gene encoding a 
PLP/PMP-containing enzyme (PMP, pyroxamine phos- 
phate). There is no obvious role for Orfs 6, 7, 8, 9 and 10 in 
the biosynthesis of rifamycin B which is not glycosylated. 
Consistent with this, inactivation of off6 and orf9 had no 
effect on rifamycin B production (L. Heide, R.M. and 
H.G.F., unpublished observations). The isolation of glyco- 
sylated rifamycin derivatives, the tolypomycins, has been 
reported from another organism, Streptomyces tolypophorus, 
that also produces rifamycin B. The sugar moiety attached 
to C-4 of the tolypomycins, a 4-amino-2,3-dideoxy-L- 
rhamnose [38], could indeed require enzymes like the 
ones encoded by orfs 6-10 for the late stages of its biosyn- 
thesis. Functionally, these genes may be silent in 
A. mediterranei $699 because no glycosylated rifamycin has 
so far been isolated from this culture, or they may be 
expressed at such low levels that their biosynthetic 
product has escaped etection. 
Upstream of off13 there seems to be a transcriptional unit 
comprised of two genes (orfl4 and off15) that encode pro- 
teins with high degrees of homology to methyl trans- 
ferases and transketolases, respectively. The off14 gene 
product shows 34% identity and 55% similarity to EryG 
that catalyzes the methylation of the 3-OH group of the 
mycarosyl moiety in erythromycin biosynthesis [39]. Orfl4 
is therefore proposed to be responsible for the O-methyla- 
tion at C-27 of rifamycin W during rifamycin B biosynthe- 
sis. Orfl5 strongly resembles transketolases from different 
organisms (52% identity and 62% similarity to cbbTofXan- 
thobacterflavus [40], 42% identity and 55% similarity to 
tktA of Synechocystissp. [41]). A second copy of this primary 
metabolic gene from the pentose phosphate pathway 
could serve to increase the production levels of erythrose- 
4-phosphate (E4P) and subsequently also of AHBA and 
rifamycin B. Frost and Draths [42] have shown in E. coli 
that overexpression of transketolases can increase carbon 
flowthrough the common pathway to E4P. 
Located between orfl5 and orfl6 are two inverted repeats; 
these two stem loops could function as terminators for the 
transcription of orfl4 and orflS, and off16, respectively. 
Finally, downstream of off13 we find an almost complete 
ORF (off12) that extends into an unsequenced region and 
shows strong homology to various thioesterase gene prod- 
ucts, such as Orf5 from the tylosin gene cluster of S.fradiae 
[43] and the thioesterase domain in the last module of the 
erythromycin PKS [22]. The function of the thioesterase 
domain in the erythromycin PKS evidently is the release of 
the completed polyketide from the enzyme as the macro- 
cyclic lactone, but thioesterase genes have also been found 
separate and distal from PKS genes in other antibiotic 
biosynthesis gene clusters, such as the tylosin gene cluster, 
and their functions are at present not known. 
Discuss ion  
In the work reported here we have sequenced a region of 
DNA from A. mediterranei spanning about 95 kb that is 
involved in the biosynthesis of the rifamycin antibiotics. 
The sequence is contiguous except for a 5 kb unse- 
quenced region on one side of the cluster and includes 
the entire sequence of a type I PKS with the correct 
number of modules required for the assembly of the 
rifamycin polyketide backbone from two acetate and 
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eight propionate units. Inactivation of genes on either 
fringe of the region suggests that the rifamycin biosyn- 
thetic gene cluster extends over the entire 95 kb region, 
and possibly even beyond this region. 
The cluster includes at least seven, possibly eight, genes  
involved in the formation of the polyketide starter unit 
AHBA. This number is larger than we had expected on 
the basis of the model for AHBA biosynthesis (Figure 1) 
which predicts only four or five genes [9]. In addition, the 
location of a key biosynthetic gene (r/fJ) almost 30 kb 
away from the AHBA synthase gene was entirely unex- 
pected. It implies that the intervening enes are all still 
part of the rifamycin biosynthetic gene cluster, despite the 
finding that some of them do not seem to be essential for 
the formation of rifamycin B itself. Thus, it appears that 
the biosynthesis of the AHBA starter unit may be more 
complicated than previously anticipated. 
The sequence data confirm the notion that the mC7N unit 
biosynthetic pathway diverges at a very early stage from 
the primary metabolic shikimate pathway, probably in the 
very first step(s). The homologies identified, however, 
give no clue as to the source of the nitrogen or the process 
by which it is introduced into aminoDAHP. It was origi- 
nally proposed to come from the amide nitrogen of gluta- 
mine by action of an amidohydrolase associated with the 
DAHP synthase [44]. No homology to known amido- 
hydrolases has been seen in the entire cluster, however. 
Yet, the end-to-end similarity of RifH with DAHP syn- 
thases from plants, except for a plastid-targeting leader 
sequence, suggests that additional enzymatic functions are 
required to form aminoDAHP. The presence of the 
quinate/shikimate d hydrogenase-homologous ene (rift) 
in the cluster is rather curious. How such an enzyme would 
fit into the current model of AHBA biosynthesis  unclear. 
One may speculate that RifI reoxidizes C-3 of amino- 
quinate or aminoshikimate when aminoDHQ or amin- 
oDHS has been aberrantly reduced. This reoxidation 
reaction would direct aminoquinate or aminoshikimate 
away from catabolic pathways and back into the mC7N 
unit biosynthetic manifold. There is at present no evidence 
to support his hypothesis, however. 
The relationship between the number and deduced func- 
tions of the five rifamycin PKS genes and the structure of 
rifamycin W and B are convincing evidence for the pro- 
posed involvement of proansamaycin X as the intermedi- 
ate produced directly from the product of the rifamycin 
PKS (Figure 2). Similar to the erythromycin and rapamycin 
PKSs, the rifamycin PKS genes appear to be colinear with 
respect to the functions in their products required to build 
the rifamycin carbon skeleton. Yet this PKS has a novel 
loading domain specifying an aromatic starter unit and 
lacks a conventional thioesterase off-loading domain at 
the end of RifE, which typically catalyzes polyketide chain 
termination in macrolide formation. RifF may substitute 
for the thioesterase by displacing the thioester linkage of 
the assembled polyketide chain to the last module of the 
PKS with the amino group of the starter unit in forming the 
unique macrolactam ring of rifamycin. A thioesterase g ne 
has been located almost 30 kb downstream of fifE, but it 
seems doubtful that this gene functions in normal polyke- 
tide chain termination. A type I PKS without a thioesterase 
domain is also present in the rapamycin biosynthetic gene 
cluster [23], in which chain termination of the polyketide 
has been postulated to occur by transfer to the amino group 
of an enzyme-bound pipecolic acid, catalyzed by the rapP 
gene product [45], and cyclization by subsequent displace- 
ment of the pipecolic acid thioester linkage to the enzyme 
by a hydroxyl group of the polyketide chain. RapP bears no 
similarity to RifF, however. 
There appear to be more modifying genes in the cluster 
than are probably required to assemble rifamycin B (e.g., 
the cluster of deoxyhexose biosynthesis genes or more 
CYP450 genes than seem necessary) whereas some 
required genes (e.g., an acyltransferase g ne to acetylate 
the 25-OH group) have not been located yet. Some of the 
missing genes may be located in the 5 kb gap between 
orfll and orfl2, which is presently being sequenced, or 
adjacent to either end of the sequenced region. The pres- 
ence of additional genes not required to produce rifamycin 
B may reflect he fact that all present rifamycin-B-produc- 
ing A. mediterranei cultures, presumably including strain 
$699, are apparently derived from the same parent [6], 
which originally produced a broad range of different 
rifamycins [46]. It was then found that addition of barbital 
to the fermentation greatly enhances rifamycin B titers and 
suppresses the formation of the other components [47], and 
subsequent strain improvement gave cultures, like $699, 
that produce predominantly rifamycin B even in the 
absence of barbital. It seems likely, therefore, that strain 
$699 still contains the genetic information to produce a 
large number of different rifamycins, but that many of 
these genes are either silent or expressed at very low levels. 
Structural modification of macrolide antibiotics has proven 
to impart significant improvements in oral bioavailability 
and more persistent serum/tissue l vels of the molecules 
[48,49]. Such changes can increase their effectiveness and 
thus they have the potential to slow the emergence of 
antibiotic resistance and can lead to the discovery of mol- 
ecules with improved antibacterial spectra. In recent years, 
success has been achieved in manipulating the structures 
of naturally produced secondary metabolites by applying 
modern methods of molecular biology [7,50]. Clearly, it 
could be profitable to apply molecular genetic methods to 
alter the structure of rifamycins with the aim of generating 
new analogs capable of overcoming emerging resistance to 
rifampicins. The multitude of potential modifying genes 
discovered in this work offers ample opportunities to alter 
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functionalities introduced after polyketide assembly by the 
inactivation of such genes. And the availability of the com- 
plete sequence of the rifamycin PKS sets the stage for the 
manipulation of the polyketide backbone structure itself 
by selective limination, addition or replacement of spe- 
cific enzyme functions or sets of enzyme functions in this 
PKS by genetic engineering. 
Significance 
The naturally occuring rifamycins and the semisynthetic 
antibiotics derived from them represent a major class of 
medically important drugs as well as being polyketides 
with a unique mode of biosynthesis in a genus of the 
Actinomycetes that has not been well-studied genetically. 
3-Amino-5-hydroxybenzoic acid (AHBA), the aromatic 
amino acid starter unit, is assembled by an unusual vari- 
ation of the shikimate pathway that appears to be consid- 
erably more complex than originally thought. This issue 
can now be investigated in detail through experiments 
using the genes we have implicated to be involved in the 
aminoshikimate pathway. Similarly, characterization f 
the rifamycin polyketide synthase (PKS) genes enables a
study of the role of the novel amide synthase gene in the 
PKS mechanism to learn if the mechanism of ansa- 
macrolide ring formation is analogous to the one used to 
make the macrolactone rings of the erythromycins. Of 
more importance, however, is the potential for modifying 
the genes we have characterized using combinatorial 
biosynthesis and targeted mutagenesis in attempts to 
produce novel forms of the rifamycins that may have 
enhanced activity or potency, especially against the 
rapidly emerging rifamycin-resistant microorganisms. 
Materials and methods 
Genera/procedures 
The E. coil strain XL-1 Blue (Stratagene) and plasmids pUC19 and 
pGEM3zf(+) (Promega, Madison, WI) were used in this work. The 
A. mediterranei strain $699, which produces predominantly rifamycin B, 
was a gift from Professor Giancarlo Lancini (Lepetit Research Labora- 
tory, Geranzano, Italy). Growth of A. mediterranei was as described 
elsewhere [10]. 
E. coil was grown on LB agar medium. Growth media were supple- 
mented with the appropriate antibiotics at the following concentrations: 
Agar plate; carbenicillin, 100mg/ml; Luria Broth; CarbeniciUin, 
50 mg/ml. Competent E. coil XL-1 Blue cells were prepared and trans- 
formed according to Sambrook et aL [51]. 
Isolation and purification of A. mediterranei genomic DNA was per- 
formed according to Hopwood et aL [52] using the Kirby protocol. Iso- 
lation of plasmid DNA from E. coil was performed using Quiagen 
(Hilden, Germany) ion exchange columns. Restriction enzymes were 
obtained from Gibco/BRL, and digestions were performed according 
to the manufacturer's instructions. 
Reagent grade chemicals were purchased from Sigma Chemical Co., 
or from EM Science. [35S]dATPo~-S (5,000 Ci/mmol) and [o~-32p]dATP 
(3,000 Ci/mmol) were obtained from Amersham Corp. 
Double-stranded DNA sequencing was performed using the chain 
termination method, (Sequenase kit, version 2.0), deazaguanosine 
dinucleotides (United States Biochemical) and [o~-35S]dATP. Addi- 
tional sequencing was performed using the Perkin Elmer Amplitaq 
Dye-terminator sequencing system and run on a Applied Biosystems 
373A or 377 automated DNA sequencer. Alignment of sequence 
contigs was performed using the DNA Star program Seqman. DNA 
sequence analysis was performed using the Intelligenetics, Inc., the 
Wisconsin Genetics Computer Group software programs versions 
7.0 and 8.1 [53], and the NCBI world wide web blast server. 
Gene library preparation 
A. mediterranei genomic DNA was partially digested with Sau3AI and 
fragments in the 30-40 kb size range were cloned into BamHI/Hpal 
digested vector pOJ446 as described by Bierman et aL [54]. A 2.3 kb 
Xhol fragment carrying the AHBA synthase gene [10] was used to 
probe this cosmid library. Southern hybridization and restriction enzyme 
mapping identified 12 clones that contained the AHBA synthase gene 
and jointly extended over a 69 kb region with the AHBA synthase gene 
in the center. Cosmid DNA flanking the AHBA synthase gene in both 
directions was sequenced as described. In addition, the 1.8 kb BamHI 
fragment containing a portion of the PKS gene from the flanking region 
of the AHBA synthase gene cluster was used as the starting point to 
probe several restriction enzyme digests of A. mediterranei genomic 
DNA. Mini-libraries of size-fractionated genomic DNA cloned in pUC19 
or pGEM3zf(+) were screened to provide multiple coverage over a 
contiguous 55 kb region of the chromosome. Clone junctions or small 
gaps that were not overlapped were filled by the PCR. The entire 
region was sequenced a minimum of two times on both strands. 
Construction of rif mutants by gene disruption or replacement 
This was accomplished by inserting a hygromycin resistance gene into 
an ORF (all cloning steps were carried out with the E. coil plasmid 
vectors described above in an E. coil dcm dam strain) and, following 
electroporative transformation of A. mediterranei, allowing that construct 
to undergo homologous recombination with the genome. The initial, 
hygromycin resistant clone produced by single crossover recombination 
was grown non-selectively to isolate the antibiotic sensitive recombinant 
resulting from a second crossover through which the vector was excised 
and the rif gene was replaced with its disrupted copy. Typically, 10 to 20 
recombinants were isolated in the initial disruption step and by screening 
several hundred clones grown without hygromycin in the medium, two to 
four gene replacement clones were obtained. An example of the use of 
this method to produce the rifK mutant is given in [10]. 
Accession numbers 
The nucleotide sequence of the rifamycin genes described in this 
paper is available from GenBank and related databases under the 
accession numbers AF040570 and AF040571. 
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